Leef Brands (LEEEF) EBITDA Margin (2025 - 2026)
Leef Brands' (LEEEF) quarterly EBITDA Margin came in at 4.55% in Q1 2026, down 737.0% year-on-year from 0.71% in Q1 2025, and down 260.74% quarter-over-quarter from 2.83% in Q1 2025.
Leef Brands (LEEEF) EBITDA Margin (2025 - 2026) Analysis & Trends
Leef Brands has disclosed EBITDA Margin across 2 years of filings, most recently posting 4.55% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Leef Brands | - | - | 4.62 Mn | -4.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.55% |
| Mar 31, 2025 | 2.83% |